April W. Armstrong, MD, MPH has been appointed as chief of the division of dermatology at the University of California (UCLA) Health and the David Geffen School of Medicine at UCLA.
Since 2015, Dr. Armstrong has served as the associate dean for clinical research at the University of Southern California (USC), where she also serves as vice chair for clinical research, director of the psoriasis program, and director of clinical trials and outcomes research.
Throughout her career, Dr. Armstrong, who is a federally funded investigator, has conducted over 150 clinical trials and published more than 400 journal articles. She holds a special interest in the care of patients with inflammatory skin diseases such as atopic dermatitis and psoriasis.
A dedicated clinical researcher, much of her research focuses on the evaluation of novel systemic and topical therapies for inflammatory skin diseases, identifying and optimizing treatment goals and comorbidities, and increasing patient access to care and treatment using technology-enabled health care delivery methods.
Dr. Armstrong also serves as the chair of the medical board at the National Psoriasis Foundation, where she uses her expertise to guide and educate clinicians and patients about psoriasis. Among some of her other positions, she also serves as a board member of the American Academy of Dermatology and Co-President of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis.
Over the years, Dr. Armstrong has been an invaluable resource to LiVDerm, having shared her knowledge and expertise with our readers through various programs and events, including our 20th Annual South Beach Symposium in 2022 and our LiVDerm Deep Dive program, Dermatology on the Frontlines.
Dr. Armstrong has stated that she is deeply honored and excited for this next chapter in her life and is looking forward to working alongside the UCLA dermatology team.
The team at LiVDerm wishes Dr. Armstrong heartfelt congratulations and great success in her new role.
